A phase II study of axitinib for biliary tract cancer refractory to gemcitabine-based chemotherapy
Latest Information Update: 02 Jul 2013
At a glance
- Drugs Axitinib (Primary)
- Indications Adenosquamous carcinoma; Biliary cancer
- Focus Biomarker; Therapeutic Use
- Acronyms AX-BC
- 19 Apr 2013 New trial record